Print This Post
Dr Leah Mursaleen
Name:
Dr Leah Mursaleen
Job Title:
Head of Research
Place of work / study:
Tell us a little about yourself:
I am the new Head of Research at Alzheimer’s Research UK. I completed my BSc and MRes in Neuroscience at the University of Sussex and her PhD at the University of Westminster, in collaboration with the School of Pharmacy at UCL. My PhD was focused on investigating novel therapeutic approaches for neurodegenerative diseases.
From 2014-2023, I worked for the charity Cure Parkinson’s, worked closely with patients, academia, the NHS, and industry to develop new research focused on slowing, stopping, and reversing Parkinson’s, liaising with other funding bodies and regulatory agencies to understand the hurdles of moving research forward. I am now excited to be applying these learnings to dementia research.
[…] financement a été fourni en partie par Alzheimer’s Research UK. Léa Mursaleenresponsable de la recherche clinique de l’organisation, a déclaré que les résultats […]
[…] financiering werd gedeeltelijk verstrekt door Alzheimer’s Research UK. Lea MursaleenDe klinisch onderzoeksdirecteur van de organisatie zei dat de bevindingen het broodnodige licht […]
[…] was provided in part by Alzheimer’s Research UK. Leah Mursaleen, head of clinical research for the organization, said the findings shed much-needed light on […]
[…] was provided in part by Alzheimer’s Research UK. Leah Mursaleen, head of clinical research for the organization, said the findings shed much-needed light on […]
[…] was provided in part by Alzheimer’s Research UK. Leah Mursaleen, head of clinical research for the organization, said the findings shed much-needed light on […]
[…] was supplied partly by Alzheimer’s Analysis UK. Leah Mursaleen, head of scientific analysis for the group, stated the findings shed much-needed gentle on elements […]
[…] was presented in aspect by Alzheimer’s Analysis British isles. Leah Mursaleen, head of scientific exploration for the group, stated the conclusions drop much-desired gentle on […]
[…] přesměrovat využití již existujících léků, pokrok by to urychlilo,“ míní například Leah Mursaleenová, šéfka organizace Alzheimer´s Research UK. Takový model vidí jako slibný pro to, aby se v první řadě dařilo rozvoj Alzheimerovy nemoci […]